u

u/ekonixlab 5.0 1 idea

Reddit r/ValueInvesting
After 1 day
N/A
1/15 min ideas
After 1 week
N/A
1/15 min ideas
After 1 month
N/A
1/15 min ideas
0 winning  /  1 losing  ·  1 positions (30d)
Net: -7.2%
By sector
Stock
1 ideas -7.2%
Top tickers (by frequency)
CRM 1 ideas
0% W -7.2%
Best and worst calls
Salesforce's growth is decelerating to 7-8% organically, but key metrics like cRPO (+14-16%), AI-related ARR (>$2.9B), and capital returns ($50B buyback) remain strong, indicating business health, not disruption. The market is overreacting to the growth slowdown and the "AI disruption" narrative, pricing the stock as if its business is structurally broken, which creates a valuation disconnect from its actual performance and future potential. The author sees an opportunity to buy a durable, cash-generative business with a growing AI segment at a compressed multiple, as the negative sentiment is not supported by the company's financial data. A true acceleration in customer churn, a collapse in cRPO growth, or failure to effectively monetize AI products could validate the bear case and invalidate this thesis.
CRM HIGH Feb 26, 01:23
TLDR
=== SUMMARY === - The post argues against the popular narrative that Salesforce (CRM) is being disrupted by AI. The author believes the market is misinterpreting a growth deceleration as a structural breakdown. - The author's thesis is that Salesforce is a durable, high-single-digit grower with a strong AI monetization strategy, and the current negative sentiment has created an attractive entry point for value investors. - Quality assessment: This is a well-reasoned, data-driven argument, not deep-dive due diligence, but far from simple speculation. It uses specific company metrics (cRPO, ARR, buybacks) to counter a prevailing market narrative. === SENTIMENT === BULLISH === TRADE IDEAS === CRM - LONG | confidence: 0.90 | sentiment: +0.70 Speaker: u/ekonixlab Thesis: 1. THE FACT: Salesforce's growth is decelerating to 7-8% organically, but key metrics like cRPO (+14-16%), AI-related ARR (>$2.9B), and capital returns ($50B buyback) remain strong, indicating business health, not disruption. 2. THE BRIDGE: The market is overreacting to the growth slowdown and the "AI disruption" narrative, pricing the stock as if its business is structurally broken, which creates a valuation disconnect from its actual performance and future potential. 3. THE VERDICT: The author sees an opportunity to buy a durable, cash-generative business with a growing AI segment at a compressed multiple, as the negative sentiment is not supported by the company's financial data. 4. RISKS: A true acceleration in customer churn, a collapse in cRPO growth, or failure to effectively monetize AI products could validate the bear case and invalidate this thesis. Timeframe: medium-term Key Points: - 7-8% organic growth is deceleration, not disruption. - AI is an expansion of the platform, not a replacement. - Backlog (cRPO) is still growing at a double-digit rate. - Large capital returns signal management's confidence. - Stock is trading on sentiment, not fundamentals.
Key Points
['7-8% organic growth is deceleration, not disruption.', 'AI is an expansion of the platform, not a replacement.', 'Backlog (cRPO) is still growing at a double-digit rate.', "Large capital returns signal management's confidence.", 'Stock is trading on sentiment, not fundamentals.']
February 26, 2026 at 01:23
Reddit r/ValueInvesting
u/ekonixlab (Reddit r/ValueInvesting) | 1 trade ideas tracked | CRM | Reddit | Buzzberg